Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient: Case report

RATIONALE: Bacterial and fungal infections in Coronavirus Disease-19 (COVID-19) patients have been inadequately investigated and reported thus far. The safety profile of tocilizumab (TCZ) administration in candidemia patient still debatable. PATIENT CONCERNS: A 54 year-old woman presenting with weak...

Descripción completa

Detalles Bibliográficos
Autores principales: Sari, Anggraini Permata, Darnindro, Nikko, Yohanes, Aryan, Mokoagow, Muhammad Ikhsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282040/
https://www.ncbi.nlm.nih.gov/pubmed/33761696
http://dx.doi.org/10.1097/MD.0000000000025173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282040/
https://www.ncbi.nlm.nih.gov/pubmed/33761696
http://dx.doi.org/10.1097/MD.0000000000025173

Ejemplares similares